...Anika received CE Mark approval for Orthovisc-T sodium hyaluronate to treat pain and restore function in...
...acid. Anika Therapeutics Inc. (NASDAQ:ANIK), Bedford, Mass. Product: Orthovisc-T sodium hyaluronate Business: Musculoskeletal Alicia Parker Anika Therapeutics Inc. Orthovisc-T...

...grew 24% to $22.1M from $17.8M in 3Q13 primarily due to sales of osteoarthritis products Orthovisc...

...Vogelxo testosterone Upsher-Smith Laboratories Inc. Hypogonadism ü Byetta exenatide AstraZeneca plc (LSE:AZN; NYSE:AZN) Diabetes ü Orthovisc...

...primarily due to increased domestic and international sales of viscosupplementation products, which include osteoarthritis treatment Orthovisc...

...to $20.8M from $19.6M in 2Q12 primarily due to increased domestics sales of osteoarthritis treatment Orthovisc...

...to $15.2M from $14.4M in 1Q12 primarily due to increased domestics sales of osteoarthritis treatment Orthovisc...

...23% to $22.6M from $18.4M in 4Q11 primarily due to sales of its osteoarthritis treatment Orthovisc...

...scale-up issue at its Bedford, Mass., manufacturing facility that prevented it from filling orders for Orthovisc...

...2Q12 revenues grew 22% to $19.6M from $16.1M in 2Q11, primarily due to sales of Orthovisc...

...$40.7 $181.5 1Q12 revenues grew 22% to $14.4M from $11.7M, primarily due to sales of Orthovisc...